The Cancer Immunotherapy Biomarker Testing Landscape.
* Context.--Cancer immunotherapy provides unprecedented rates of durable clinical benefit to late-stage cancer patients across many tumor types, but there remains a critical need for biomarkers to accurately predict clinical response. Although some cancer immunotherapy tests are associated with appr...
| Publicado en: | Archives of Pathology & Laboratory Medicine Vol. 144; no. 6; pp. 706 - 725 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
College of American Pathologists
Jun2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |